MENU
CYCC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cyclacel Pharmaceuticals (CYCC) Ownership - Who owns Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
200 Connell Drive
Phone
+1 908 517-7330
Employees
12
Web
https://cyclacel.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
50.48M
P/E Ratio
N/A
Total Cash
2.98M
Projected Growth
N/A
Total Debt
N/A
Revenue
74K
Risk (Beta)
-0.21
Dividend Yield
N/A
Total Cash/Share
0.01
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
Fundamentals
CYCC
Capitalization
50.5M
P/E Ratio
N/A
Risk (Beta)
-0.21
Dividend Yield
N/A
Total Cash
2.98M
Total Cash/Share
0.01
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
74K
ROE
N/A
Book Value
-970K
P/B Ratio
0.81
Cash Flow
N/A
Earnings
-27.4
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
0.77
Current Revenue Per Employee
10714.29
Dividends Per Share - Security
N/A
EBITDA
-15.47M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-150.81
Shares Held By Institutions
264K
Shares Outstanding - Current
206M
Total Liabilities
6.35M
Total Volume MTD
N/A
Value
1
Gain YTD
-38.830
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of mechanism-targeted drugs to treat human cancers
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
200 Connell Drive
Phone
+1 908 517-7330
Employees
12
Web
https://cyclacel.com